Effectiveness of Supportive Psychotherapy Through Internet-Based Teleconsultation on Psychological and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post Covid-19 Syndrome Patients
Post-COVID-19 Syndrome
About this trial
This is an interventional treatment trial for Post-COVID-19 Syndrome
Eligibility Criteria
Inclusion Criteria: Age 18 years or over Patients confirmed positive for SARS CoV-2 by molecular testing (SARS CoV-2 RT-PCR, naso-oropharyngeal swab) at least 3 months before recruitment, with symptoms and effects lasting for at least 2 months and not explained by alternative diagnoses other Patients with or without comorbidities: diabetes mellitus, hypertension, tuberculosis, asthma, chronic obstructive pulmonary disease, chronic kidney disease, heart disease, chronic liver disease, malignancy, nervous system disease, patients with vulnerability, patients with disabilities. Patients can communicate and are willing to be interviewed, fill out questionnaires and psychotherapy. The patient is willing to fill out and sign an informed 1 sheet of consent to participate in the study Exclusion Criteria: Psychosis Can not access internet for psychotherapy Not willing to take part in the research
Sites / Locations
- Cipto Mangunkusumo Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Supportive Psychotherapy
Education
supportive psychotherapy will be given in the form of an online group for 3 times a week with a duration of psychotherapy ranging from 1 - 2 hours per session
education about post covid-19 syndrome will be given in the form of an online group for 3 times a week with a duration about 1 - 2 hours per session